FR 901277

Drug Profile

FR 901277

Alternative Names: WS 7622A

Latest Information Update: 17 Jul 2002

Price : $50

At a glance

  • Originator Fujisawa
  • Class
  • Mechanism of Action Leucocyte elastase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Emphysema

Most Recent Events

  • 08 Jun 2001 Profile reviewed but no significant changes made
  • 23 Jun 1998 Commercial data have been reviewed by Fujisawa
  • 20 Feb 1997 New profile
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top